Shares of Edinburgh-based Craneware, a provider of software for the US healthcare market, rose about 12% on Tuesday after it published a trading update for its AGM.

“The first four months of this fiscal year saw a return to strong sales growth, considerably ahead of the equivalent period of the prior year,” said Craneware.

“Results are ahead of management expectations for this stage in the year and, we expect revenues and adjusted EBITDA for the Interim period to 31 December 2020 to be ahead of the equivalent period in the prior year, building the foundation for a return to double-digit growth in the future …

“We continue to see substantial new opportunities entering the sales pipeline and the board is confident in the continued strong performance of the business.”